Investment Boom

Cue up "We're in the Money," please, this time for life sciences businesses. Venture Capital funds are flowing freely into the life sciences sector so far this year – up 25 percent by value in the second quarter, according to a new analysis.

The new MoneyTree report from PriceWaterhouse Cooper's and the National Venture Capital Association finds that VCs pumped $2.5 billion into life sciences deals in the second quarter, compared to $2 billion in the same period last year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Raising Money

Another Go-Round?

R&D Concentration

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.